Compositions and Methods for Inhibiting Expression of Transthyretin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160264963A1
SERIAL NO

14965825

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a transthyretin (TTR) gene, and methods of using the dsRNA to inhibit expression of TTR.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC675 WEST KENDALL STREET HENRI A TERMEER SQUARE CAMBRIDGE MA 02142-1110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alvarez, Rene Boxborough, US 25 259
Chen, Qingmin Lincoln, US 26 238
Hinkle, Gregory Plymouth, US 164 786
Milstein, Stuart Cambridge, US 133 755
Sah, Dinah Wen-Yee Boston, US 85 907

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation